Silvercrest Asset Management’s Idexx Laboratories IDXX Stock Holding History

Silvercrest Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$456K	Sell	867 -5	-0.6%	-$2.8K	﹤0.01%	713
2026 Q1	$490K	Sell	872 -80	-8%	-$51.3K	﹤0.01%	690
2025 Q4	$644K	Sell	952 -996	-51%	-$678K	﹤0.01%	674
2025 Q3	$1.24M	Sell	1,948 -635	-25%	-$385K	0.01%	590
2025 Q2	$1.39M	Buy	2,583 +5	+0.2%	+$2.39K	0.01%	594
2025 Q1	$1.08M	Buy	2,578 +1,108	+75%	+$481K	0.01%	613
2024 Q4	$608K	Hold	1,470	–	–	﹤0.01%	665
2024 Q3	$743K	Hold	1,470	–	–	0.01%	600
2024 Q2	$716K	Hold	1,470	–	–	﹤0.01%	665
2024 Q1	$794K	Sell	1,470 -1	-0.1%	-$546	0.01%	644
2023 Q4	$816K	Buy	1,471 +49	+3%	+$23K	0.01%	609
2023 Q3	$622K	Hold	1,422	–	–	﹤0.01%	652
2023 Q2	$714K	Sell	1,422 -1,018	-42%	-$488K	0.01%	635
2023 Q1	$1.22M	Hold	2,440	–	–	0.01%	547
2022 Q4	$995K	Hold	2,440	–	–	0.01%	581
2022 Q3	$795K	Hold	2,440	–	–	0.01%	588
2022 Q2	$856K	Hold	2,440	–	–	0.01%	585
2022 Q1	$1.33M	Sell	2,440 -1	-0%	-$526	0.01%	561
2021 Q4	$1.61M	Hold	2,441	–	–	0.01%	508
2021 Q3	$1.52M	Buy	+2,441	New	+$1.64M	0.01%	519

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Silvercrest Asset Management's IDXX Position: Q2 2026 in Review

Silvercrest Asset Management reduced its Idexx Laboratories (IDXX) stake by 0.57% in Q2 2026, selling an estimated $2.8K and leaving 867 shares worth $456K. The position accounts for ﹤0.01% of the portfolio, ranked #713.

Silvercrest Asset Management first reported a position in IDXX in Q3 2021 and has held it in 20 quarters since. The position peaked at $1.61M in Q4 2021. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Silvercrest Asset Management held 867 shares of Idexx Laboratories worth $456K as of Q2 2026.
Silvercrest Asset Management sold 5 Idexx Laboratories shares in Q2 2026, an estimated $2.8K.
Idexx Laboratories made up ﹤0.01% of Silvercrest Asset Management's portfolio in Q2 2026, its #713 holding.
Silvercrest Asset Management first reported a position in Idexx Laboratories in Q3 2021 and has held it in 20 quarters since.
Silvercrest Asset Management's Idexx Laboratories position peaked at $1.61M in Q4 2021.
1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Silvercrest Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.